Marc Raspanti | Philadelphia Litigation Lawyer

Mr. Marc S. Raspanti

Mr. Marc S. Raspanti

Government, Health Care, Litigation, Health Care Other, Commercial Litigation, Government Enforcement, White Collar Litigation, Internal Investigations. Qui Tam & False Claims Act

Premium Member Premium Member
Language(s): English

Premium Member
Verified Highlights

Premium Badge In Good Standing
Premium Badge No Misconduct Found
Premium Badge Reviews Pro Bono Cases

Main Office

1818 Market St
Suite 3402
Philadelphia, PA 19103

Office Hours

Other Locations

Pietragallo Gordon Alfano Bosick & Raspanti, LLP is a multi-disciplined business and commercial litigation firm headquartered in Pittsburgh with five offices throughout Pennsylvania, New Jersey, and West Virginia from which we serve our clients in all 50 states and the District of Columbia.

Pietragallo Gordon Alfano Bosick & Raspanti, LLP

About Marc

MARC STEPHEN RASPANTI is a seasoned trial lawyer with over 41 years of experience focusing on complex, high-stakes matters in Government Enforcement, Compliance, Internal Investigations, Federal and State White Collar Litigation; Federal and State Qui Tam Litigation; Criminal, Civil and Administrative Health Care Fraud Litigation; as well as Complex Commercial Litigation. Chambers USA has ranked Mr. Raspanti in Band 1 for his work in the area of Litigation: White Collar Crime & Government Investigations in Pennsylvania, as well as Band 1 for his work under the False Claims Act: Plaintiff in the USA- Nationwide.

Mr. Raspanti is a longstanding Fellow of the American College of Trial Lawyers, an invitation only fellowship of pre-eminent lawyers in the United States and Canada. He served as a former Assistant District Attorney at the Philadelphia District Attorney’s Office where he tried a wide range of criminal cases to verdict. Mr. Raspanti is the founder of the firm’s national Qui Tam & False Claims Act practice group and the firm’s national White Collar Criminal Defense practice group.

Over his career, Mr. Raspanti has represented numerous executives, corporations, physicians, health care providers, pharmacists, surgeons, clinical laboratories, healthcare systems, manufacturers, distributors, medical device companies, entrepreneurs, clergy, accountants, lawyers, politicians, and professionals in numerous federal, state and regulatory investigations throughout the country and abroad.

Call to discuss my fee structure.

Admission

Verified New York

2008

Verified District of Columbia

1993

Verified Pennsylvania

1984

Verified District 1

Verified Florida

Education

Beasley School of Law, Temple University

J.D.

Recognitions & Achievements

Associations
  • U.S. Supreme Court
  • U.S. Court of Appeals for the Second Circuit
  • U.S. Court of Appeals for the Third Circuit
  • U.S. Court of Appeals for the Fourth Circuit
  • U.S. Court of Appeals for the Eleventh Circuit
  • U.S. District Court – Eastern District of Pennsylvania
  • U.S. District Court – Middle District of Pennsylvania
  • U.S. District Court – Western District of Pennsylvania
  • U.S. District Court – Southern District of New York
Honors / Awards
  • Clients describe Mr. Raspanti in Chambers USA as being “excellent in his field” and “an outstanding strategist.” Mr. Raspanti has been named “One of the best white collar criminal defense lawyers in Philadelphia” by Philadelphia Magazine; selected by his peers annually since as a Pennsylvania Super Lawyer; selected as one of the “Top 100” in Pennsylvania by Super Lawyers; selected as one of the “Top 100” in Philadelphia by Super Lawyers; “Lawyer of the Year” for the Philadelphia Health Care sector for and ; and selected by his peers annually since as part of The Best Lawyers in America® in the areas of Qui Tam Law, Health Care Law, Corporate Compliance Law, and Criminal Defense: White-Collar. He is also recognized in the edition of Legal 500 as a Tier 1 lawyer for his work in White-Collar Crime in Philadelphia. In , Mr. Raspanti was the recipient of the prestigious Cesare Beccaria Award by the Justinian Society of Philadelphia and the Criminal Justice Section of the Philadelphia Bar Association.
    2004 / 2018 / 2024 / 2006 / 2026 / 2016

Notable Work

Publications

BLOG: Is Finality Still Useful in False Claims Act Litigation?


An Emerging Opportunity for the States to Revitalize Their State False Claims Act Enforcement


BLOG: What Will the Art of Jury Selection Look Like During Trump’s Second Presidency?


BLOG: When Is Mediation Most Effective for False Claims Act Cases?


Physician Open Payments June 30th Data Publication to Incorporate New Final Rule Changes


Unmasking the Power of the Anti-Fraud Injunction Statute


BLOG: Marc Raspanti and Pamela Coyle Brecht's WOLEP ation Released

Present


Laboratory Fraud: What Was Old is New Again


Are Courts Still the Best Place to Litigate a Qui Tam Action?


The Physician Payments Sunshine Act and the Future of Healthcare Transparency: Part 2


The Physician Payments Sunshine Act and the Future of Healthcare Transparency: Part 1


The differences and similarities between American and Italian healthcare fraud, waste, and abuse laws: Part 3


The differences and similarities between American and Italian healthcare fraud, waste, and abuse laws: Part 2


The differences and similarities between American and Italian healthcare fraud, waste, and abuse laws: Part 1


Are You FCPA Compliant?


Conducting Investigations During a Pandemic: The New Normal


International Whistleblowing Legislation and America’s False Claims Act


BLOG: International Whistleblowing Legislation and America's False Claims Act


Vive La Différence? American and French Healthcare Fraud, Waste, and Abuse Laws


The Impact of International Whistleblowing on Global Corporate Compliance


Tips For Reing Corporations, Employees In Government Investigations

present


Exit Interviews – Do the Benefits Outweigh the Risks? In The Legal Intelligencer


Hiding in Plain Sight: Obtaining Insurance Coverage in White Collar Criminal Investigations and Complex Civil Litigation


BLOG: Ontario’s First Whistleblower Award of $7.5 Million


BLOG: The Irish Paradox: A Tale of Two Whistleblower Laws


BLOG: Alberta, Canada Passes Its Version Of A Whistleblower Program


BLOG: SEC Pushes To Cap Whistleblower Rewards


BLOG: Blowing The Whistle: Italian Style


False Claims Act Cases Against Hospital Corporations


BLOG: Whistleblowing: French Style


BLOG: September Has Been A Transitional Month For FCPA Prosecutions In Latin America


BLOG: The French Connection


BLOG: A Billion Dollar Venezuelan Bribery And Money Laundering Scheme Unfolds


BLOG: A Special Prosecutor - Another Way To Look At It For The Trump Administration


The Future of FCPA Enforcement Under the Trump Administration


BLOG: The Future Of FCPA Enforcement Under The Trump Administration


A Practitioner’s Primer on History and Use of the Federal Anti-Kickback Statute


A New Era Of Laboratory Fraud: Part 2


A New Era Of Laboratory Fraud: Part 1


Working Both Sides Of The Corporate Crime Aisle


Criminal Investigations Of Compounding Pharmacies On The Rise In

2016


BLOG: Dermatologist Wins Defense Verdict In Virginia Federal Court


BLOG: What The Yates Memo Means For Federal Criminal And Civil Corporate Investigations


The SEC’s New Admissions Policy Means Sometimes Having To Say You’re Sorry


Failure To Report To ODC: Violation Or Larger Problem?


BLOG: Miranda: The Public Safety Exception


A Philadelphia Federal Judge Gives Major Part D Case The Green Light


Who Is Enforcing The Stark Law Of The United States?


THE TAR HEEL STATE STEPS UP ITS FIGHT AGAINST FRAUD – PART II


THE TAR HEEL STATE STEPS UP ITS FIGHT AGAINST FRAUD


What’s Next For The Year-Old SEC Whistleblower Program?


Why Is Qui Tam Litigation Often So Difficult To Resolve?


The IRS’ Proposed Amendments To Its Informant Award Program


Proposed Sec Rules Undermine Dodd-Frank’s Whistleblower Incentives


Sen. Stevens’ Tragic Demise Breathed Life Into Brady


Defense Contracting Fraud Prosecutions: Is The Past Prologue?


THE MINNESOTA FALSE CLAIMS ACT: IS IT MINNESOTA NICE?


States, Statutes And Fraud: A Study Of Emerging State Efforts To Combat White Collar Crime


Daubert Challenges To Experts In Federal Criminal Cases: A Still Underutilized Defense


Anatomy Of A Federal Health Care Fraud Prosecution


A Sea Change In Government Contracts Comes With Policy Alterations


THE EMPLOYMENT PROTECTION AND ANTI-DISCRIMINATION PROVISIONS OF THE NEW JERSEY STATE FALSE CLAIMS ACT


THE ‘NEW’ NEW JERSEY FALSE CLAIMS ACT: IT WAS BORN TO RUN


Compliance And Governance For Health Care Organizations And Marketing And Sales Activities


Will An Internal Independent Investigation Always Make A Difference To A Corporation?


Why Do They Do It?: The Motives, Mores, And Character Of White Collar Criminals


Modern False Claims Act Liability: Cradle To Grave Liability?


False Claims Act Damages: One Size Doesn’t Fit All


States, Statutes, And Fraud: An Empirical Study Of Emerging State False Claims Acts


When Does Economic Credentialing Violate The Anti-Kickback Statute


Deterring Employees From Becoming Whistleblowers And Defending Against Whistleblower Suits Brought By Employees


The Whistleblower Wanted More


Analysis & Perspective- A Case Study: Department Of Justice V. Qui Tam Relators


Whistleblowers: Merena & Partners Win $52 Million; Judge Breaks New Ground On Qui Tam Issues


The Qui Tam Provisions Of The False Claims Act: Theory, Practice And Procedure


The Qui Tam Provisions Of The False Claims Act: Success Has Its Challenges

Pietragallo Gordon Alfano Bosick & Raspanti, LLP Highlights

Litigation, Government, Class Action, Products Liability, Government Enforcement, Compliance, & White Collar Litigation Qui Tam & False Claims Act Title IX & Sexual Misconduct

Firm Size: 1
Firm Locations: 1

Premium Member Mr. Marc S. Raspanti has been a Premium Member since March 04, 2026.

Many of our longest-standing Premium Members have built strong reputations over time. We highlight their experience to help you make informed choices with confidence.